Developments FDA approves PharmaTher’s KETARx for surgical pain management PharmaTher Holdings (QTCQB: PHRRF; CSE: PHRM) has announced that the FDA has approved its ketamine product, KETARx, for use in surgical pain management. According to PharmaTher, the approval positions the company to... August 11, 2025